Skip to Main Content

Paper Details

Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: a cohort study.
J Immunother Cancer
2
2023
LUADs, PD, PD-(L)1, PD-L1, PD-L11, PD-L150, advanced LUADs, advanced lung adenocarcinomas, patients
Author NameAffiliation
Hira RizviMemorial Sloan Kettering Cancer Center
Charles M RudinMemorial Sloan Kettering Cancer Center
Charles M RudinWeill Cornell Medical College
Gregory J RielyMemorial Sloan Kettering Cancer Center
Gregory J RielyWeill Cornell Medical College
Marc LadanyiMemorial Sloan Kettering Cancer Center
Marc LadanyiMemorial Sloan Kettering Cancer Center
Ronglai ShenMemorial Sloan Kettering Cancer Center
  • 1 - 8

Datasets

Release 1.2